title: [Parathyroid gland intervention therapy for patients with secondary hyperparathyroidism due to dialysis].
authors.forename: Noritaka
authors.initials: N
authors.lastname: Onoda
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Kashiwagi
authors.forename: Tadashi
authors.initials: T
authors.lastname: Nakamura
authors.forename: Yoshifumi
authors.initials: Y
authors.lastname: Niitsu
authors.forename: Momoyo
authors.initials: M
authors.lastname: Omata
authors.forename: Satoshi
authors.initials: S
authors.lastname: Kurihara
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood; D003956:Dialysis / Q000009:adverse effects; D000431:Ethanol / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D010280:Parathyroid Glands / Q000000981:diagnostic imaging / Q000637:transplantation; D010281:Parathyroid Hormone / Q000097:blood; D016105:Parathyroidectomy; D017410:Practice Guidelines as Topic; D014463:Ultrasonography; D014807:Vitamin D / Q000008:administration & dosage
chemical_list: D015415:Biomarkers; D010281:Parathyroid Hormone; D014807:Vitamin D; D000431:Ethanol